Off Label Drug Use Cases

Explore 2 court opinions on Off Label Drug Use. AI-powered plain English summaries, key holdings, and legal analysis.

2 recent cases analyzed in this topic area.

Courts Deciding Off Label Drug Use Cases

Recent Off Label Drug Use Opinions (2)

Novartis Pharmaceuticals Corp v. Secretary United States Department of Health

Third Circuit Upholds Medicare Part D Drug Exclusion

ca3 · 2025-09-11 · Defendant Win · Impact: 30/100

Novartis Pharmaceuticals Corp v. Secretary United States Department of Health, decided by Third Circuit on September 11, 2025, resulted in a defendant win outcome. The Third Circuit affirmed the Distr...

Actavis Laboratories Fl, Inc. v. United States

Federal Circuit Clarifies Medicare Part D 'Substantially All' Drug Reimbursement Rule

cafc · 2025-03-21 · Defendant Win · Impact: 40/100

Actavis Laboratories Fl, Inc. v. United States, decided by Federal Circuit on March 21, 2025, resulted in a defendant win outcome. The case concerns the interpretation of the "substantially all" limit...

Off Label Drug Use by Court

Supreme Court First Circuit Second Circuit Third Circuit Fourth Circuit Fifth Circuit Sixth Circuit Seventh Circuit Eighth Circuit Ninth Circuit Tenth Circuit Eleventh Circuit D.C. Circuit Federal Circuit

Off Label Drug Use by State

California Texas New York Florida Illinois Pennsylvania Ohio Georgia Michigan New Jersey Virginia Washington Massachusetts North Carolina

Related Resources

off-label-drug-use Legal Definition off-label-drug-use Practice Area Guide off-label-drug-use Landmarks Home Search Cases States Courts Topic Rankings